Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/27/24 16:39 | 11/26/24 | NGNE | Health | Drug | Pharmaceutical Preparations | Samsara Biocapital Gp, LLC | CA | T | P | 1,260 | 25.83 | 0 | 49 | 3 | 1,717 | I | |||||||||||||||
11/25/24 21:29 | 11/22/24 | NGNE | Health | Drug | Pharmaceutical Preparations | Cvijic Christine Mikail | NY | O | P,CFO | P | 491 | 20.48 | 0 | 24 | 45 | 77 | D | ||||||||||||||
11/25/24 21:29 | 11/22/24 | NGNE | Health | Drug | Pharmaceutical Preparations | McMinn Rachel | NY | DO | CEO | P | 969 | 20.40 | 0 | 48 | 4 | 1,298 | D | ||||||||||||||
8/17/23 17:08 | 8/15/23 | NLTX | Health | Drug | Pharmaceutical Preparations | Baker Bros. Advisors LP | NY | DT | P.m | 1,463 | 0.6404 | 0 | 2,285 | 69 | 5,617 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |